#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune haemolytic anaemia Chronic inflammatory demyelinating polyradiculoneuropathy Alveolar rhabdomyosarcoma Uveitis Pleomorphic liposarcoma Haemophilia Systemic mastocytosis Pemphigus Immune-mediated enterocolitis Inclusion body myositis Neuroblastoma Pulmonary arterial hypertension Myotonic dystrophy Antiphospholipid antibodies Multiple system atrophy More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Treatment Richter’s syndrome – Basic Information Mast cell activation syndrome – Trials in Disease Brain stem glioma – Trials in Disease Turner’s syndrome Focal segmental glomerulosclerosis Paroxysmal nocturnal haemoglobinuria Phenylketonuria – Trials in Disease Systemic mastocytosis Antithrombin III deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Granisetron Onasemnogene Abeparvovec BI 456906 SODIUM TETRACHLOROPALLADATE Brexpiprazole Imipenem Tranexamic Acid Tolinapant Lactate Retifanlimab Lumasiran Milademetan Azd8630 Ianalumab Ovolecithin Stro-002 Elezanumab Cefoxitin Sodium Bms-986442 Gr0015 Vanglusagene Ensiparvovec More therapies…

    Learn about Your Condition

    Hepatitis alcoholic Back pain Sinusitis bacterial Neuroblastoma Micrographic skin surgery Prodromal Alzheimer's disease Diabetes mellitus Bladder cancer stage II Retinal artery occlusion Venous thrombosis Insomnia Hyperplasia adrenal Leber's congenital amaurosis Arterial disorder Urinary incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ductal adenocarcinoma of pancreas

  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    Belgium Czechia Denmark Finland France Germany +4

  • Study of RR001 with Gemcitabine and Paclitaxel for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Autologous Human Adipose Perivascular Stromal Cells Genetically Modified To Secrete Soluble Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    Italy

  • Study of fluorouracil, irinotecan and oxaliplatin combination therapy for patients with metastatic pancreatic ductal adenocarcinoma who progressed after gemcitabine treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Levoleucovorin
    • Levoleucovorin Disodium
    • Fluorouracil
    Belgium

  • Study on the Safety and Effects of [68Ga]Ga-DPI-4452 and [177Lu]Lu-DPI-4452 in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Clear cell renal cell carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • 177Lu-Dpi-4452
    • 68Ga-Dpi-4452
    • Acetazolamide
    Belgium France

  • Study on the Safety and Effectiveness of MK-2870 Alone or with Other Drugs for Patients with Colorectal, Pancreatic, and Biliary Tract Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Ductal adenocarcinoma of pancreas
    • Colorectal cancer
    Investigated Drugs:
    • H2-Receptor Antagonists
    • Calcium Folinate
    • Buclizine Hydrochloride
    Italy Spain

  • Study on Propranolol for Reducing Anxiety in Patients with Pancreatic Cancer Before Surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Placebo
    • Propranolol
    Denmark
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!